Aron Thall Selected Research

utomilumab

1/2020	First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20+ Non-Hodgkin Lymphomas.
12/2019	A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aron Thall Research Topics

Disease

3	Fatigue 01/2021 - 12/2013
3	Neoplasms (Cancer) 12/2019 - 02/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2013 - 11/2010
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2020 - 07/2005
2	Lymphoma (Lymphomas) 01/2020 - 07/2005
1	Exanthema (Rash) 01/2021
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	Nausea 01/2021
1	Asthenia 12/2013
1	Diarrhea 12/2013
1	Myocardial Infarction 02/2013
1	Mesothelioma 02/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2011
1	Adenocarcinoma 07/2011
1	Brain Neoplasms (Brain Tumor) 07/2011
1	Anemia 07/2005
1	Febrile Neutropenia 07/2005
1	Cytopenia 07/2005

Drug/Important Bio-Agent (IBA)

4	Sunitinib (Sutent)FDA Link 12/2013 - 11/2010
2	utomilumabIBA 01/2020 - 12/2019
2	Monoclonal AntibodiesIBA 12/2019 - 07/2005
2	Pemetrexed (MTA)FDA Link 12/2013 - 02/2013
2	Cisplatin (Platino)FDA LinkGeneric 02/2013 - 11/2010
1	B7-H1 AntigenIBA 01/2021
1	avelumabIBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Rituximab (Mabthera)FDA Link 01/2020
1	mogamulizumabIBA 12/2019
1	AntibodiesIBA 12/2019
1	CC ChemokinesIBA 12/2019
1	LigandsIBA 12/2019
1	Pharmaceutical PreparationsIBA 12/2013
1	Carboplatin (JM8)FDA LinkGeneric 12/2013
1	Gemcitabine FDA Link 11/2010
1	Biological ProductsIBA 07/2005
1	galiximabIBA 07/2005

Therapy/Procedure

2	Therapeutics 07/2011 - 07/2005
1	Aftercare (After-Treatment) 07/2005